Merrimack Pharmaceuticals Falls Back To Support Following JPMorgan Downgrade
October 07, 2016 at 10:41 AM EDT
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) shares are trading lower by $0.23 at $5.75 in Friday's session. The catalyst for the ...